Innovative health and wellness products from Vivalyf Innovations are aimed at controlling and preventing lifestyle disorders including diabetes and high blood pressure. The Vivalyf Smart Glucometer, the company’s flagship product, is a smart device that tracks glucose levels and helps monitor blood sugar levels in real time. It also seamlessly integrates with a mobile app for continuous tracking. The business markets itself as a leader in providing people with chronic illnesses with reasonably priced healthcare options.

Company Name: Vivalyf Innovations

Founder: Duvvuru Varshita, Vimal Kumar

Product: Prickless Diabetes Testing Machine

Highlights

• The entrepreneur wants to establish the brand as a major force in the health-tech sector by growing the company and extending the reach of their cutting-edge health solutions.
• Vimal described how the demand for accessible, reasonably priced solutions for managing chronic diseases especially for those with diabetes led to the creation of Vivalyf Innovations. He underlined that the company wants to change the healthcare industry by providing smart gadgets that can help people manage lifestyle disorders by giving them access to real-time health data so they can make better decisions.
• In addition to praising the product’s potential in the healthcare industry, Ashneer expressed worries over its scalability and the competitive environment in the health-tech sector.
• Aman acknowledged the potential market size and innovation, especially in the diabetic category. He questioned the product’s demonstrated success and rapid growth, nevertheless.
• The demand for reasonably priced healthcare solutions and the health-tech component piqued Namita’s interest. She chose to decline the agreement, nevertheless, because she was worried about the competitive environment and the sales traction.
• Anupam wanted additional information regarding the traction and scalability of the firm and questioned the valuation. intrigued by the ecosystem of digital health that the app and device have produced.
• Peyush acknowledged the product’s promise but expressed doubts about its capacity to successfully enter the market. talked about how crucial marketing and branding are to this industry’s expansion.
• Peyush and anupam offered ₹56 Lakhs for 33.33% Equity and owners countered offer of ₹36 lakhs for 15% Equity and ₹20 lakhs debt for 3 Years but sharks denied and remain on their offer.

Pitch Details

Ask:₹ 56 lakhs for 7.5% equity.

Deal: After negotiations, Peyush and Anupam together secured a deal for ₹56 Lakhs for 33.33% equity.

Investors: The investment came from Peyush Bansal and Anupam Mittal.

Conclusion

Vivalyf Innovations overcame obstacles with valuation and scalability to earn a deal on Shark Tank India Season 1, Episode 8. The Sharks were drawn to the company’s emphasis on offering reasonably priced healthcare solutions, particularly for the management of chronic illnesses like diabetes. Its cutting-edge smartphone app-enabled smart glucometer demonstrated the expanding possibilities of health technology in India.The equity offered was significantly reduced as a result of the Sharks’ worries regarding the competitive market and the high value.

With an investment of ₹56 lakhs for 33.33% ownership, Vivalyf Innovations was able to demonstrate the Sharks’ more cautious approach. In the cutthroat health-tech sector, this transaction highlights the significance of reasonable valuations as well as the necessity of market traction and scalability. The business now has the chance to take use of Anupam Mittal and Peyush Bansal’s networks and experience to boost market penetration, branding, and growth—particularly in the rapidly growing digital health industry.

Significant findings

• Health-Tech Innovation
• Scalability Concerns
• Valuation Disagreement
• Market Penetration